Literature DB >> 6697826

Use of the seton in the treatment of extrasphincteric anal fistula.

H C Kuypers.   

Abstract

Ten extrasphincteric fistulas have been treated by the two-stage seton procedure. The seton was left in situ for three months; follow-up varied from six months to 2 1/2 years. There were no recurrences. Six patients experienced slight soiling and one patient became incontinent. Provided that only muscle tissue is enclosed by the seton, the procedure gives good results; a diverting colostomy is not necessary.

Entities:  

Mesh:

Year:  1984        PMID: 6697826     DOI: 10.1007/bf02553987

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  The surgical management of fistula-in-ano in a specialist colorectal unit.

Authors:  M Davies; D Harris; P Lohana; T V Chandra Sekaran; A R Morgan; J Beynon; N D Carr
Journal:  Int J Colorectal Dis       Date:  2008-04-22       Impact factor: 2.571

2.  Can the external anal sphincter be preserved in the treatment of trans-sphincteric fistula-in-ano?

Authors:  J P Thomson; A H Ross
Journal:  Int J Colorectal Dis       Date:  1989-12       Impact factor: 2.571

3.  The use of the loose seton technique as a definitive treatment for recurrent and persistent high trans-sphincteric anal fistulas: a long-term outcome.

Authors:  Arieh Eitan; Marina Koliada; Amitai Bickel
Journal:  J Gastrointest Surg       Date:  2009-02-24       Impact factor: 3.452

4.  Fistulas in ano: endoanal ultrasonographic assessment assists decision making for surgery.

Authors:  K I Deen; J G Williams; R Hutchinson; M R Keighley; D Kumar
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Seton treatment for perianal Crohn's fistulas.

Authors:  K Koganei; A Sugita; H Harada; T Fukushima; H Shimada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

6.  Hybrid seton for the treatment of high anal fistulas: results of 128 consecutive patients.

Authors:  B Ege; S Leventoğlu; B B Menteş; U Yılmaz; A Y Öner
Journal:  Tech Coloproctol       Date:  2013-04-30       Impact factor: 3.781

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.